Cerba Lancet Africa has entered into a strategic partnership with International Clinical Laboratories in Ethiopia to enhance local diagnostic services and improve healthcare access.
Information on the Target
International Clinical Laboratories (ICL) is a prominent private medical laboratory in Ethiopia, recognized for its exceptional service in the biomedical field. Over the past 17 years, ICL has treated over 3 million patients and established itself as the leading provider of laboratory diagnostics in the country. The laboratory’s extensive geographic presence and commitment to quality have positioned it as a vital player in responding to public health needs, especially during the COVID-19 pandemic.
Industry Overview in Ethiopia
Ethiopia’s healthcare system has faced significant challenges, exacerbated by the COVID-19 pandemic. The pandemic highlighted vulnerabilities in health systems worldwide, revealing the critical need for robust diagnostic and testing services. As a result, the demand for advanced laboratory facilities and diagnostic tools has risen sharply.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Ethiopian government has been working towards strengthening healthcare infrastructure, which includes enhancing laboratory services. International investme
Similar Deals
Boston Scientific → Nalu Medical
2026
Barça Innovation Hub → Omniscope
2025
Otsuka Pharmaceutical Co., Ltd. → 4D Molecular Therapeutics
2025
Cressey & Company LP → Paradigm Health
2025
Welsh, Carson, Anderson & Stowe → Constitution Surgery Alliance
2025
Cerba HealthCare
invested in
International Clinical Laboratories (ICL) Éthiopie
in 2022
in a Strategic Partnership deal